Cardiac Mapping Market by Product (Contact Mapping Systems (Electroanatomical Mapping, Basket Catheter Mapping), Non-contact Mapping Systems), Indication (Atrial Fibrillation, Atrial Flutter, AVNRT), Region - Global Forecast to 2024
“The cardiac mapping market is projected to grow at a CAGR of 8.7% during the forecast period.”
The global cardiac mapping market size is projected to reach USD 2.1 billion by 2024 from USD 1.4 billion in 2019 at a CAGR of 8.7%. The emergence of new entrants, growing investments, funds, and grants, increasing incidences of target diseases, and growth in the geriatric population are supporting the growth of this market. However, unfavorable healthcare reforms in the US and the lack of skilled & experienced electrophysiologists may restrain the market to a certain extent during the forecast period.
“The contact cardiac mapping segment is projected to dominate the cardiac mapping products market during the forecast period.”
The cardiac mapping products market has been segmented into contact cardiac mapping systems and non-contact cardiac mapping systems. The contact cardiac mapping systems segment further includes electroanatomical mapping, basket catheter mapping, and traditional endocardial mapping. The contact cardiac mapping systems segment held the largest share of this market in 2018 and is also estimated to grow at the highest CAGR during the forecast period. Contact mapping systems are technologically more efficient and precise, hence, they provide higher accuracy, sensitivity, and efficiency in disease diagnosis and ablation.
“The atrial fibrillation applications segment held the largest market share in 2018.”
By indication, the cardiac mapping market is segmented into atrial fibrillation, atrial flutter, atrioventricular nodal reentry tachycardia (AVNRT), other arrhythmias. The atrial fibrillation segment accounted for the largest share of this market in 2018. The large share of this segment can be attributed to the technological advancements in mapping systems and the rising incidences of AF and associated ablation procedures.
“The North American cardiac mapping market is expected to hold the largest share during the forecast period.”
Geographically, the cardiac mapping industry is segmented into North America, Europe, Asia Pacific (APAC), and the Rest of the World. North America is expected to hold the largest share of this market during the forecast period. The increase in approval rate of mapping systems and clinical trials validating cardiac mapping systems in the US, high incidence of CVDs, and growing focus of government organizations on providing funding for cardiological research are the key factors driving the North American market.
Breakdown of supply-side primary interviews:
Research Coverage
This report studies the cardiac mapping market based on product, indication, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets concerning their growth trends and forecasts the revenue of the market segments for four main regions and respective countries.
Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the cardiac mapping market, and high-growth regions with their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.
The global cardiac mapping market size is projected to reach USD 2.1 billion by 2024 from USD 1.4 billion in 2019 at a CAGR of 8.7%. The emergence of new entrants, growing investments, funds, and grants, increasing incidences of target diseases, and growth in the geriatric population are supporting the growth of this market. However, unfavorable healthcare reforms in the US and the lack of skilled & experienced electrophysiologists may restrain the market to a certain extent during the forecast period.
“The contact cardiac mapping segment is projected to dominate the cardiac mapping products market during the forecast period.”
The cardiac mapping products market has been segmented into contact cardiac mapping systems and non-contact cardiac mapping systems. The contact cardiac mapping systems segment further includes electroanatomical mapping, basket catheter mapping, and traditional endocardial mapping. The contact cardiac mapping systems segment held the largest share of this market in 2018 and is also estimated to grow at the highest CAGR during the forecast period. Contact mapping systems are technologically more efficient and precise, hence, they provide higher accuracy, sensitivity, and efficiency in disease diagnosis and ablation.
“The atrial fibrillation applications segment held the largest market share in 2018.”
By indication, the cardiac mapping market is segmented into atrial fibrillation, atrial flutter, atrioventricular nodal reentry tachycardia (AVNRT), other arrhythmias. The atrial fibrillation segment accounted for the largest share of this market in 2018. The large share of this segment can be attributed to the technological advancements in mapping systems and the rising incidences of AF and associated ablation procedures.
“The North American cardiac mapping market is expected to hold the largest share during the forecast period.”
Geographically, the cardiac mapping industry is segmented into North America, Europe, Asia Pacific (APAC), and the Rest of the World. North America is expected to hold the largest share of this market during the forecast period. The increase in approval rate of mapping systems and clinical trials validating cardiac mapping systems in the US, high incidence of CVDs, and growing focus of government organizations on providing funding for cardiological research are the key factors driving the North American market.
Breakdown of supply-side primary interviews:
- By Company Type: Tier 1 – 50%, Tier 2 – 30%, and Tier 3 – 20%
- By Designation: C-level – 37%, Director-level – 29%, and Others – 34%
- By Region: North America - 35%, Europe – 30%, APAC – 25%, and RoW – 10%
Research Coverage
This report studies the cardiac mapping market based on product, indication, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets concerning their growth trends and forecasts the revenue of the market segments for four main regions and respective countries.
Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the cardiac mapping market, and high-growth regions with their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.2 RESEARCH METHODOLOGY STEPS
2.2.1 SECONDARY DATA
2.2.1.1 Secondary sources
2.2.2 PRIMARY DATA
2.2.2.1 Key insights from primary sources
2.2.3 MARKET SIZE ESTIMATION METHODOLOGY
2.2.4 REVENUE MAPPING-BASED MARKET ESTIMATION
2.3 MARKET DATA ESTIMATION AND TRIANGULATION
2.4 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 CARDIAC MAPPING SYSTEMS MARKET OVERVIEW
4.2 GEOGRAPHIC ANALYSIS: EUROPEAN CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION & COUNTRY (2019)
4.3 CARDIAC MAPPING SYSTEMS MARKET SHARE, BY TYPE, 2019 VS. 2024
4.4 CARDIAC MAPPING SYSTEMS MARKET SHARE, BY INDICATION, 2019 VS. 2024
4.5 GEOGRAPHIC OUTLOOK: CARDIAC MAPPING SYSTEMS MARKET
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 New entrants in the market
5.2.1.2 Growing investments, funds, and grants
5.2.1.3 Increasing incidence of target diseases
5.2.1.4 Growth in the geriatric population
5.2.2 RESTRAINTS
5.2.2.1 Unfavorable healthcare reforms in the US
5.2.2.2 Lack of skilled and experienced electrophysiologists
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging markets
5.2.3.2 Technological advancements
5.2.4 CHALLENGES
5.2.4.1 Unfavorable regulatory scenario
5.2.4.2 Alternative technologies
6 CARDIAC MAPPING SYSTEMS MARKET, BY TYPE
6.1 INTRODUCTION
6.2 CONTACT CARDIAC MAPPING SYSTEMS
6.2.1 ELECTROANATOMICAL MAPPING SYSTEMS
6.2.1.1 Electroanatomical mapping systems account for the largest share of the contact cardiac mapping systems market
6.2.2 BASKET CATHETER MAPPING SYSTEMS
6.2.2.1 Basket catheter mapping systems provide simultaneous, multiple, stable recordings for most endocardial surfaces— a key factor driving market growth
6.2.3 TRADITIONAL ENDOCARDIAL CONTACT MAPPING SYSTEMS
6.2.3.1 Exposure to ionizing radiation due to the need for fluoroscopy guidance is a key disadvantage of traditional endocardial contact mapping systems
6.3 NON-CONTACT CARDIAC MAPPING SYSTEMS
6.3.1 ADVANTAGE OF NON-CONTACT CARDIAC MAPPING IN CASES WHERE
THE ARRHYTHMIA CANNOT BE TOLERATED OR WHERE CLINICAL
ARRHYTHMIA IS NOT REPRODUCIBLE—A KEY DRIVER
7 CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION
7.1 INTRODUCTION
7.2 ATRIAL FIBRILLATION
7.2.1 GROWING NUMBER OF ATRIAL FIBRILLATION CASES AND THE SUBSEQUENT INCREASE IN THE NUMBER OF ABLATION PROCEDURES TO DRIVE
MARKET GROWTH
7.3 ATRIAL FLUTTER
7.3.1 HIGH SUCCESS RATE OF RADIOFREQUENCY CATHETER ABLATION FOR
THE TREATMENT OF ATRIAL FLUTTER IS A MAJOR FACTOR CONTRIBUTING TO THE GROWTH OF THIS MARKET
7.4 ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA (AVNRT)
7.4.1 GROWING NUMBER OF AVNRT CASES ACROSS THE GLOBE IS SUPPORTING THE GROWTH OF THIS SEGMENT
7.5 OTHER ARRHYTHMIAS
8 CARDIAC MAPPING SYSTEMS MARKET, BY REGION
8.1 INTRODUCTION
8.2 NORTH AMERICA
8.2.1 US
8.2.1.1 High burden of CVDs to drive the demand for cardiac mapping systems in the US
8.2.2 CANADA
8.2.2.1 Growing focus of government organizations on providing research funding to support market growth in Canada
8.3 EUROPE
8.3.1 GERMANY
8.3.1.1 Favorable healthcare expenditure and growing use of CRT devices to drive market growth
8.3.2 UK
8.3.2.1 Growing geriatric population to support market growth
8.3.3 FRANCE
8.3.3.1 Increasing incidence of heart failure to support market growth
8.3.4 ITALY
8.3.4.1 Increasing incidence of CVD to drive the adoption of cardiac
mapping systems
8.3.5 SPAIN
8.3.5.1 Growing number of cardiac ablation procedures to drive the market
in Spain
8.3.6 REST OF EUROPE
8.4 ASIA PACIFIC
8.4.1 JAPAN
8.4.1.1 Favorable reimbursement scenario to support market growth
8.4.2 CHINA
8.4.2.1 Growing geriatric population to drive the market for cardiac
mapping systems
8.4.3 INDIA
8.4.3.1 Increasing government initiatives towards healthcare are supporting the growth of the cardiac mapping systems market in India
8.4.4 REST OF ASIA PACIFIC
8.5 REST OF THE WORLD
9 COMPETITIVE LANDSCAPE
9.1 INTRODUCTION
9.2 MARKET RANKING ANALYSIS
9.3 COMPETITIVE LEADERSHIP MAPPING (OVERALL MARKET)
9.3.1 VISIONARY LEADERS
9.3.2 INNOVATORS
9.3.3 EMERGING COMPANIES
9.3.4 DYNAMIC DIFFERENTIATORS
9.4 COMPETITIVE SCENARIO
9.4.1 PRODUCT LAUNCHES & APPROVALS
9.4.2 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
9.4.3 ACQUISITIONS
10 COMPANY PROFILES
(Business overview, Products offered, Recent developments, Competitive Analysis)*
10.1 BIOSENSE WEBSTER, INC. (A JOHNSON & JOHNSON COMPANY)
10.2 ABBOTT LABORATORIES
10.3 BOSTON SCIENTIFIC CORPORATION
10.4 MEDTRONIC PLC
10.5 MICROPORT SCIENTIFIC CORPORATION
10.6 EP SOLUTIONS SA
10.7 ACUTUS MEDICAL
10.8 KONINKLIJKE PHILIPS N.V.
10.9 LEPU MEDICAL
10.10 BIOTRONIK
10.11 ANGIODYNAMICS
10.12 BIOSIG TECHNOLOGIES, INC.
10.13 APN HEALTH, LLC
10.14 COREMAP
10.15 KARDIUM, INC.
10.16 CATHETER PRECISION, INC.
10.17 EPMAP-SYSTEM
*Business overview, Products offered, Recent developments, Competitive Analysis might not be captured in case of unlisted companies.
11 APPENDIX
11.1 DISCUSSION GUIDE
11.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
11.3 AVAILABLE CUSTOMIZATIONS
11.4 RELATED REPORTS
11.5 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.2 RESEARCH METHODOLOGY STEPS
2.2.1 SECONDARY DATA
2.2.1.1 Secondary sources
2.2.2 PRIMARY DATA
2.2.2.1 Key insights from primary sources
2.2.3 MARKET SIZE ESTIMATION METHODOLOGY
2.2.4 REVENUE MAPPING-BASED MARKET ESTIMATION
2.3 MARKET DATA ESTIMATION AND TRIANGULATION
2.4 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 CARDIAC MAPPING SYSTEMS MARKET OVERVIEW
4.2 GEOGRAPHIC ANALYSIS: EUROPEAN CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION & COUNTRY (2019)
4.3 CARDIAC MAPPING SYSTEMS MARKET SHARE, BY TYPE, 2019 VS. 2024
4.4 CARDIAC MAPPING SYSTEMS MARKET SHARE, BY INDICATION, 2019 VS. 2024
4.5 GEOGRAPHIC OUTLOOK: CARDIAC MAPPING SYSTEMS MARKET
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 New entrants in the market
5.2.1.2 Growing investments, funds, and grants
5.2.1.3 Increasing incidence of target diseases
5.2.1.4 Growth in the geriatric population
5.2.2 RESTRAINTS
5.2.2.1 Unfavorable healthcare reforms in the US
5.2.2.2 Lack of skilled and experienced electrophysiologists
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging markets
5.2.3.2 Technological advancements
5.2.4 CHALLENGES
5.2.4.1 Unfavorable regulatory scenario
5.2.4.2 Alternative technologies
6 CARDIAC MAPPING SYSTEMS MARKET, BY TYPE
6.1 INTRODUCTION
6.2 CONTACT CARDIAC MAPPING SYSTEMS
6.2.1 ELECTROANATOMICAL MAPPING SYSTEMS
6.2.1.1 Electroanatomical mapping systems account for the largest share of the contact cardiac mapping systems market
6.2.2 BASKET CATHETER MAPPING SYSTEMS
6.2.2.1 Basket catheter mapping systems provide simultaneous, multiple, stable recordings for most endocardial surfaces— a key factor driving market growth
6.2.3 TRADITIONAL ENDOCARDIAL CONTACT MAPPING SYSTEMS
6.2.3.1 Exposure to ionizing radiation due to the need for fluoroscopy guidance is a key disadvantage of traditional endocardial contact mapping systems
6.3 NON-CONTACT CARDIAC MAPPING SYSTEMS
6.3.1 ADVANTAGE OF NON-CONTACT CARDIAC MAPPING IN CASES WHERE
THE ARRHYTHMIA CANNOT BE TOLERATED OR WHERE CLINICAL
ARRHYTHMIA IS NOT REPRODUCIBLE—A KEY DRIVER
7 CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION
7.1 INTRODUCTION
7.2 ATRIAL FIBRILLATION
7.2.1 GROWING NUMBER OF ATRIAL FIBRILLATION CASES AND THE SUBSEQUENT INCREASE IN THE NUMBER OF ABLATION PROCEDURES TO DRIVE
MARKET GROWTH
7.3 ATRIAL FLUTTER
7.3.1 HIGH SUCCESS RATE OF RADIOFREQUENCY CATHETER ABLATION FOR
THE TREATMENT OF ATRIAL FLUTTER IS A MAJOR FACTOR CONTRIBUTING TO THE GROWTH OF THIS MARKET
7.4 ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA (AVNRT)
7.4.1 GROWING NUMBER OF AVNRT CASES ACROSS THE GLOBE IS SUPPORTING THE GROWTH OF THIS SEGMENT
7.5 OTHER ARRHYTHMIAS
8 CARDIAC MAPPING SYSTEMS MARKET, BY REGION
8.1 INTRODUCTION
8.2 NORTH AMERICA
8.2.1 US
8.2.1.1 High burden of CVDs to drive the demand for cardiac mapping systems in the US
8.2.2 CANADA
8.2.2.1 Growing focus of government organizations on providing research funding to support market growth in Canada
8.3 EUROPE
8.3.1 GERMANY
8.3.1.1 Favorable healthcare expenditure and growing use of CRT devices to drive market growth
8.3.2 UK
8.3.2.1 Growing geriatric population to support market growth
8.3.3 FRANCE
8.3.3.1 Increasing incidence of heart failure to support market growth
8.3.4 ITALY
8.3.4.1 Increasing incidence of CVD to drive the adoption of cardiac
mapping systems
8.3.5 SPAIN
8.3.5.1 Growing number of cardiac ablation procedures to drive the market
in Spain
8.3.6 REST OF EUROPE
8.4 ASIA PACIFIC
8.4.1 JAPAN
8.4.1.1 Favorable reimbursement scenario to support market growth
8.4.2 CHINA
8.4.2.1 Growing geriatric population to drive the market for cardiac
mapping systems
8.4.3 INDIA
8.4.3.1 Increasing government initiatives towards healthcare are supporting the growth of the cardiac mapping systems market in India
8.4.4 REST OF ASIA PACIFIC
8.5 REST OF THE WORLD
9 COMPETITIVE LANDSCAPE
9.1 INTRODUCTION
9.2 MARKET RANKING ANALYSIS
9.3 COMPETITIVE LEADERSHIP MAPPING (OVERALL MARKET)
9.3.1 VISIONARY LEADERS
9.3.2 INNOVATORS
9.3.3 EMERGING COMPANIES
9.3.4 DYNAMIC DIFFERENTIATORS
9.4 COMPETITIVE SCENARIO
9.4.1 PRODUCT LAUNCHES & APPROVALS
9.4.2 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
9.4.3 ACQUISITIONS
10 COMPANY PROFILES
(Business overview, Products offered, Recent developments, Competitive Analysis)*
10.1 BIOSENSE WEBSTER, INC. (A JOHNSON & JOHNSON COMPANY)
10.2 ABBOTT LABORATORIES
10.3 BOSTON SCIENTIFIC CORPORATION
10.4 MEDTRONIC PLC
10.5 MICROPORT SCIENTIFIC CORPORATION
10.6 EP SOLUTIONS SA
10.7 ACUTUS MEDICAL
10.8 KONINKLIJKE PHILIPS N.V.
10.9 LEPU MEDICAL
10.10 BIOTRONIK
10.11 ANGIODYNAMICS
10.12 BIOSIG TECHNOLOGIES, INC.
10.13 APN HEALTH, LLC
10.14 COREMAP
10.15 KARDIUM, INC.
10.16 CATHETER PRECISION, INC.
10.17 EPMAP-SYSTEM
*Business overview, Products offered, Recent developments, Competitive Analysis might not be captured in case of unlisted companies.
11 APPENDIX
11.1 DISCUSSION GUIDE
11.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
11.3 AVAILABLE CUSTOMIZATIONS
11.4 RELATED REPORTS
11.5 AUTHOR DETAILS
LIST OF TABLES
TABLE 1 NEW ENTRANTS IN THE CARDIAC MAPPING SYSTEMS MARKET
TABLE 2 POPULATION STATISTICS, 2015 VS. 2030 VS. 2050 (MILLION INDIVIDUALS)
TABLE 3 CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 4 CARDIAC MAPPING SYSTEMS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 5 CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 6 CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 7 NORTH AMERICA: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 8 EUROPE: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 9 APAC: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 10 ELECTROANATOMICAL MAPPING SYSTEMS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 11 NORTH AMERICA: ELECTROANATOMICAL MAPPING SYSTEMS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 12 EUROPE: ELECTROANATOMICAL MAPPING SYSTEMS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 13 APAC: ELECTROANATOMICAL MAPPING SYSTEMS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 14 BASKET CATHETER MAPPING SYSTEMS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 15 NORTH AMERICA: BASKET CATHETER MAPPING SYSTEMS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 16 EUROPE: BASKET CATHETER MAPPING SYSTEMS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 17 APAC: BASKET CATHETER MAPPING SYSTEMS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 18 TRADITIONAL ENDOCARDIAL CONTACT MAPPING SYSTEMS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 19 NORTH AMERICA: TRADITIONAL ENDOCARDIAL CONTACT MAPPING SYSTEMS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 20 EUROPE: TRADITIONAL ENDOCARDIAL CONTACT MAPPING SYSTEMS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 21 APAC: TRADITIONAL ENDOCARDIAL CONTACT MAPPING SYSTEMS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 22 NON-CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 23 NORTH AMERICA: NON-CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 24 EUROPE: NON-CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 25 APAC: NON-CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 26 CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2017–2024 (USD MILLION)
TABLE 27 CARDIAC MAPPING SYSTEMS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 28 CARDIAC MAPPING SYSTEMS MARKET FOR ATRIAL FIBRILLATION, BY REGION, 2017–2024 (USD MILLION)
TABLE 29 NORTH AMERICA: CARDIAC MAPPING SYSTEMS MARKET FOR ATRIAL FIBRILLATION, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 30 EUROPE: CARDIAC MAPPING SYSTEMS MARKET FOR ATRIAL FIBRILLATION, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 31 APAC: CARDIAC MAPPING SYSTEMS MARKET FOR ATRIAL FIBRILLATION, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 32 CARDIAC MAPPING SYSTEMS MARKET FOR ATRIAL FLUTTER, BY REGION, 2017–2024 (USD MILLION)
TABLE 33 NORTH AMERICA: CARDIAC MAPPING SYSTEMS MARKET FOR ATRIAL FLUTTER, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 34 EUROPE: CARDIAC MAPPING SYSTEMS MARKET FOR ATRIAL FLUTTER, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 35 APAC: CARDIAC MAPPING SYSTEMS MARKET FOR ATRIAL FLUTTER, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 36 CARDIAC MAPPING SYSTEMS MARKET FOR ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA , BY REGION, 2017–2024 (USD MILLION)
TABLE 37 NORTH AMERICA: CARDIAC MAPPING SYSTEMS MARKET FOR ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 38 EUROPE: CARDIAC MAPPING SYSTEMS MARKET FOR ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 39 APAC: CARDIAC MAPPING SYSTEMS MARKET FOR ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 40 CARDIAC MAPPING SYSTEMS MARKET FOR OTHER ARRHYTHMIAS, BY REGION, 2017–2024 (USD MILLION)
TABLE 41 NORTH AMERICA: CARDIAC MAPPING SYSTEMS MARKET FOR OTHER ARRHYTHMIAS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 42 EUROPE: CARDIAC MAPPING SYSTEMS MARKET FOR OTHER ARRHYTHMIAS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 43 APAC: CARDIAC MAPPING SYSTEMS MARKET FOR OTHER ARRHYTHMIAS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 44 CARDIAC MAPPING SYSTEMS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 45 NORTH AMERICA: CARDIAC MAPPING SYSTEMS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 46 NORTH AMERICA: CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 47 NORTH AMERICA: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 48 NORTH AMERICA: CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2017–2024 (USD MILLION)
TABLE 49 CLINICAL TRIALS RELATED TO CARDIAC MAPPING DEVICES
TABLE 50 US: CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 51 US: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 52 US: CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2017–2024 (USD MILLION)
TABLE 53 RESEARCH GRANTS TOWARDS RESEARCH IN CARDIOLOGY
TABLE 54 CANADA: CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 55 CANADA: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 56 CANADA: CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2017–2024 (USD MILLION)
TABLE 57 EUROPE: CARDIAC MAPPING SYSTEMS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 58 EUROPE: CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 59 EUROPE: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 60 EUROPE: CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2017–2024 (USD MILLION)
TABLE 61 GERMANY: CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 62 GERMANY: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 63 GERMANY: CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2017–2024 (USD MILLION)
TABLE 64 UK: CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 65 UK: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 66 UK: CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2017–2024 (USD MILLION)
TABLE 67 FRANCE: CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 68 FRANCE: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 69 FRANCE: CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2017–2024 (USD MILLION)
TABLE 70 ITALY: CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 71 ITALY: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 72 ITALY: CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2017–2024 (USD MILLION)
TABLE 73 SPAIN: CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 74 SPAIN: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 75 SPAIN: CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2017–2024 (USD MILLION)
TABLE 76 CARDIAC AF ABLATION PROCEDURES, BY COUNTRY, 2015 VS. 2016
TABLE 77 ROE: CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 78 ROE: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 79 ROE: CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2017–2024 (USD MILLION)
TABLE 80 APAC: CARDIAC MAPPING SYSTEMS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 81 APAC: CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 82 APAC: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 83 APAC: CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2017–2024 (USD MILLION)
TABLE 84 JAPAN: CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 85 JAPAN: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 86 JAPAN: CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2017–2024 (USD MILLION)
TABLE 87 CHINA: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 88 CHINA: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 89 CHINA: CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2017–2024 (USD MILLION)
TABLE 90 INDIA: CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 91 INDIA: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 92 INDIA: CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2017–2024 (USD MILLION)
TABLE 93 ROAPAC: CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 94 ROAPAC: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 95 ROAPAC: CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2017–2024 (USD MILLION)
TABLE 96 ROW: CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 97 ROW: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 98 ROW: CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2017–2024 (USD MILLION)
TABLE 99 RIGHT-TO-WIN
TABLE 100 PRODUCT LAUNCHES & APPROVALS (2017–2019)
TABLE 101 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2017–2019)
TABLE 102 ACQUISITIONS (2017–2019)
TABLE 1 NEW ENTRANTS IN THE CARDIAC MAPPING SYSTEMS MARKET
TABLE 2 POPULATION STATISTICS, 2015 VS. 2030 VS. 2050 (MILLION INDIVIDUALS)
TABLE 3 CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 4 CARDIAC MAPPING SYSTEMS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 5 CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 6 CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 7 NORTH AMERICA: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 8 EUROPE: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 9 APAC: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 10 ELECTROANATOMICAL MAPPING SYSTEMS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 11 NORTH AMERICA: ELECTROANATOMICAL MAPPING SYSTEMS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 12 EUROPE: ELECTROANATOMICAL MAPPING SYSTEMS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 13 APAC: ELECTROANATOMICAL MAPPING SYSTEMS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 14 BASKET CATHETER MAPPING SYSTEMS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 15 NORTH AMERICA: BASKET CATHETER MAPPING SYSTEMS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 16 EUROPE: BASKET CATHETER MAPPING SYSTEMS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 17 APAC: BASKET CATHETER MAPPING SYSTEMS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 18 TRADITIONAL ENDOCARDIAL CONTACT MAPPING SYSTEMS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 19 NORTH AMERICA: TRADITIONAL ENDOCARDIAL CONTACT MAPPING SYSTEMS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 20 EUROPE: TRADITIONAL ENDOCARDIAL CONTACT MAPPING SYSTEMS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 21 APAC: TRADITIONAL ENDOCARDIAL CONTACT MAPPING SYSTEMS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 22 NON-CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 23 NORTH AMERICA: NON-CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 24 EUROPE: NON-CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 25 APAC: NON-CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 26 CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2017–2024 (USD MILLION)
TABLE 27 CARDIAC MAPPING SYSTEMS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 28 CARDIAC MAPPING SYSTEMS MARKET FOR ATRIAL FIBRILLATION, BY REGION, 2017–2024 (USD MILLION)
TABLE 29 NORTH AMERICA: CARDIAC MAPPING SYSTEMS MARKET FOR ATRIAL FIBRILLATION, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 30 EUROPE: CARDIAC MAPPING SYSTEMS MARKET FOR ATRIAL FIBRILLATION, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 31 APAC: CARDIAC MAPPING SYSTEMS MARKET FOR ATRIAL FIBRILLATION, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 32 CARDIAC MAPPING SYSTEMS MARKET FOR ATRIAL FLUTTER, BY REGION, 2017–2024 (USD MILLION)
TABLE 33 NORTH AMERICA: CARDIAC MAPPING SYSTEMS MARKET FOR ATRIAL FLUTTER, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 34 EUROPE: CARDIAC MAPPING SYSTEMS MARKET FOR ATRIAL FLUTTER, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 35 APAC: CARDIAC MAPPING SYSTEMS MARKET FOR ATRIAL FLUTTER, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 36 CARDIAC MAPPING SYSTEMS MARKET FOR ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA , BY REGION, 2017–2024 (USD MILLION)
TABLE 37 NORTH AMERICA: CARDIAC MAPPING SYSTEMS MARKET FOR ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 38 EUROPE: CARDIAC MAPPING SYSTEMS MARKET FOR ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 39 APAC: CARDIAC MAPPING SYSTEMS MARKET FOR ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 40 CARDIAC MAPPING SYSTEMS MARKET FOR OTHER ARRHYTHMIAS, BY REGION, 2017–2024 (USD MILLION)
TABLE 41 NORTH AMERICA: CARDIAC MAPPING SYSTEMS MARKET FOR OTHER ARRHYTHMIAS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 42 EUROPE: CARDIAC MAPPING SYSTEMS MARKET FOR OTHER ARRHYTHMIAS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 43 APAC: CARDIAC MAPPING SYSTEMS MARKET FOR OTHER ARRHYTHMIAS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 44 CARDIAC MAPPING SYSTEMS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 45 NORTH AMERICA: CARDIAC MAPPING SYSTEMS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 46 NORTH AMERICA: CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 47 NORTH AMERICA: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 48 NORTH AMERICA: CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2017–2024 (USD MILLION)
TABLE 49 CLINICAL TRIALS RELATED TO CARDIAC MAPPING DEVICES
TABLE 50 US: CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 51 US: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 52 US: CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2017–2024 (USD MILLION)
TABLE 53 RESEARCH GRANTS TOWARDS RESEARCH IN CARDIOLOGY
TABLE 54 CANADA: CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 55 CANADA: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 56 CANADA: CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2017–2024 (USD MILLION)
TABLE 57 EUROPE: CARDIAC MAPPING SYSTEMS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 58 EUROPE: CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 59 EUROPE: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 60 EUROPE: CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2017–2024 (USD MILLION)
TABLE 61 GERMANY: CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 62 GERMANY: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 63 GERMANY: CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2017–2024 (USD MILLION)
TABLE 64 UK: CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 65 UK: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 66 UK: CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2017–2024 (USD MILLION)
TABLE 67 FRANCE: CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 68 FRANCE: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 69 FRANCE: CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2017–2024 (USD MILLION)
TABLE 70 ITALY: CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 71 ITALY: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 72 ITALY: CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2017–2024 (USD MILLION)
TABLE 73 SPAIN: CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 74 SPAIN: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 75 SPAIN: CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2017–2024 (USD MILLION)
TABLE 76 CARDIAC AF ABLATION PROCEDURES, BY COUNTRY, 2015 VS. 2016
TABLE 77 ROE: CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 78 ROE: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 79 ROE: CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2017–2024 (USD MILLION)
TABLE 80 APAC: CARDIAC MAPPING SYSTEMS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 81 APAC: CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 82 APAC: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 83 APAC: CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2017–2024 (USD MILLION)
TABLE 84 JAPAN: CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 85 JAPAN: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 86 JAPAN: CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2017–2024 (USD MILLION)
TABLE 87 CHINA: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 88 CHINA: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 89 CHINA: CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2017–2024 (USD MILLION)
TABLE 90 INDIA: CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 91 INDIA: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 92 INDIA: CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2017–2024 (USD MILLION)
TABLE 93 ROAPAC: CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 94 ROAPAC: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 95 ROAPAC: CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2017–2024 (USD MILLION)
TABLE 96 ROW: CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 97 ROW: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 98 ROW: CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2017–2024 (USD MILLION)
TABLE 99 RIGHT-TO-WIN
TABLE 100 PRODUCT LAUNCHES & APPROVALS (2017–2019)
TABLE 101 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2017–2019)
TABLE 102 ACQUISITIONS (2017–2019)
LIST OF FIGURES
FIGURE 1 RESEARCH METHODOLOGY: CARDIAC MAPPING SYSTEMS MARKET
FIGURE 2 RESEARCH DESIGN
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 5 DATA TRIANGULATION METHODOLOGY
FIGURE 6 CARDIAC MAPPING SYSTEMS MARKET SHARE, BY TYPE, 2019
FIGURE 7 CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2019 VS. 2024 (USD MILLION)
FIGURE 8 GEOGRAPHICAL SNAPSHOT OF THE CARDIAC MAPPING SYSTEMS MARKET
FIGURE 9 INCREASING INCIDENCE OF TARGET DISEASES AND ENTRY OF NEW PLAYERS TO DRIVE THE GROWTH OF THE MARKET
FIGURE 10 ATRIAL FIBRILLATION TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPEAN CARDIAC MAPPING SYSTEMS MARKET IN 2019
FIGURE 11 CONTACT CARDIAC MAPPING SYSTEMS TO DOMINATE THE CARDIAC MAPPING SYSTEMS MARKET DURING THE FORECAST PERIOD
FIGURE 12 ATRIAL FIBRILLATION TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2019
FIGURE 13 APAC TO REGISTER THE HIGHEST CAGR IN THE FORECAST PERIOD
FIGURE 14 CARDIAC MAPPING SYSTEMS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 15 CARDIAC MAPPING SYSTEMS MARKET, BY REGION, 2019 VS. 2024
FIGURE 16 NORTH AMERICA: CARDIAC MAPPING SYSTEMS MARKET SNAPSHOT
FIGURE 17 ASIA PACIFIC: CARDIAC MAPPING SYSTEMS MARKET SNAPSHOT
FIGURE 18 KEY DEVELOPMENTS IN THE CARDIAC MAPPING SYSTEMS MARKET, 2017–2019
FIGURE 19 CARDIAC MAPPING SYSTEMS MARKET RANKING ANALYSIS, BY KEY PLAYER, 2018
FIGURE 20 CARDIAC MAPPING SYSTEMS MARKET COMPETITIVE LEADERSHIP MAPPING, 2018
FIGURE 21 ABBOTT LABORATORIES: COMPANY SNAPSHOT
FIGURE 22 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
FIGURE 23 MEDTRONIC PLC: COMPANY SNAPSHOT
FIGURE 24 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
FIGURE 25 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
FIGURE 26 LEPU MEDICAL: COMPANY SNAPSHOT (2017)
FIGURE 27 ANGIODYNAMICS: COMPANY SNAPSHOT
FIGURE 1 RESEARCH METHODOLOGY: CARDIAC MAPPING SYSTEMS MARKET
FIGURE 2 RESEARCH DESIGN
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 5 DATA TRIANGULATION METHODOLOGY
FIGURE 6 CARDIAC MAPPING SYSTEMS MARKET SHARE, BY TYPE, 2019
FIGURE 7 CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2019 VS. 2024 (USD MILLION)
FIGURE 8 GEOGRAPHICAL SNAPSHOT OF THE CARDIAC MAPPING SYSTEMS MARKET
FIGURE 9 INCREASING INCIDENCE OF TARGET DISEASES AND ENTRY OF NEW PLAYERS TO DRIVE THE GROWTH OF THE MARKET
FIGURE 10 ATRIAL FIBRILLATION TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPEAN CARDIAC MAPPING SYSTEMS MARKET IN 2019
FIGURE 11 CONTACT CARDIAC MAPPING SYSTEMS TO DOMINATE THE CARDIAC MAPPING SYSTEMS MARKET DURING THE FORECAST PERIOD
FIGURE 12 ATRIAL FIBRILLATION TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2019
FIGURE 13 APAC TO REGISTER THE HIGHEST CAGR IN THE FORECAST PERIOD
FIGURE 14 CARDIAC MAPPING SYSTEMS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 15 CARDIAC MAPPING SYSTEMS MARKET, BY REGION, 2019 VS. 2024
FIGURE 16 NORTH AMERICA: CARDIAC MAPPING SYSTEMS MARKET SNAPSHOT
FIGURE 17 ASIA PACIFIC: CARDIAC MAPPING SYSTEMS MARKET SNAPSHOT
FIGURE 18 KEY DEVELOPMENTS IN THE CARDIAC MAPPING SYSTEMS MARKET, 2017–2019
FIGURE 19 CARDIAC MAPPING SYSTEMS MARKET RANKING ANALYSIS, BY KEY PLAYER, 2018
FIGURE 20 CARDIAC MAPPING SYSTEMS MARKET COMPETITIVE LEADERSHIP MAPPING, 2018
FIGURE 21 ABBOTT LABORATORIES: COMPANY SNAPSHOT
FIGURE 22 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
FIGURE 23 MEDTRONIC PLC: COMPANY SNAPSHOT
FIGURE 24 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
FIGURE 25 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
FIGURE 26 LEPU MEDICAL: COMPANY SNAPSHOT (2017)
FIGURE 27 ANGIODYNAMICS: COMPANY SNAPSHOT
